Agilent Technologies, Inc. (A) vs Biogen Inc. (BIIB)
A side-by-side comparison of Agilent Technologies, Inc. and Biogen Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 29, 2026. Differences are shown without an overall score or investment verdict.
A
Agilent Technologies, Inc.
$140.31HealthcareDelayed quote: Jul 29, 2026, 3:59 PM EDT
BIIB
Biogen Inc.
$209.23HealthcareDelayed quote: Jul 29, 2026, 4:00 PM EDT
Total return — A vs BIIB
growth of $100 · dividends reinvested · last 27yA +452.2%BIIB +940.0%BIIB compounded faster
A BIIB
A vs BIIB: by the numbers
- •A is the larger company ($39.63B vs $30.89B market cap).
- •BIIB trades at the lower trailing earnings multiple (22.01 vs 28.22 P/E), one valuation lens rather than an overall verdict.
- •A converts more revenue to profit (19.55% vs 8.39% net margin).
- •A grew revenue faster over the past five years (4.45% vs -3.19% CAGR).
- •A pays a dividend (0.72% yield), while BIIB has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | A | BIIB |
|---|---|---|
| P/E ratio | 28.22 | 22.01 |
| Forward P/E | 23.21 | 16.28 |
| P/S ratio | 5.52 | 3.10 |
| P/B ratio | 5.60 | 1.64 |
| PEG ratio | 9.44 | N/A |
| EV / EBITDA | 22.63 | 13.86 |
| FCF yield | 3.15% | 8.60% |
Profitability
| Metric | A | BIIB |
|---|---|---|
| Gross margin | 53.00% | 70.47% |
| Operating margin | 21.50% | 19.14% |
| Net margin | 19.55% | 8.39% |
| ROE | 19.85% | 4.48% |
| ROIC | 12.57% | 6.62% |
Dividends
| Metric | A | BIIB |
|---|---|---|
| Dividend yield | 0.72% | N/A |
| Payout ratio | 22.07% | N/A |
Growth (annualized)
| Metric | A | BIIB |
|---|---|---|
| Revenue CAGR (5Y) | 4.45% | -3.19% |
| EPS CAGR (5Y) | 14.52% | -18.67% |
| FCF CAGR (5Y) | 0.05% | -11.63% |
| Total return CAGR (5Y) | -0.79% | -9.26% |
Frequently asked
- Which has the lower trailing P/E, A or BIIB?
- BIIB has the lower trailing P/E: A trades at 28.22 and BIIB at 22.01. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, A or BIIB?
- Over the past five years, A grew revenue faster — A at a 4.45% CAGR versus BIIB at -3.19%.
- Does A or BIIB pay a bigger dividend?
- A pays a dividend (0.72% yield), while BIIB has no payments in the available dividend history.
- Is A or BIIB more profitable?
- A runs the higher net margin — A at 19.55% versus BIIB at 8.39%.
- How have A and BIIB total returns compared?
- Over the past 10 years, A delivered 12.33% and BIIB delivered -3.35% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Agilent Technologies P/E ratioBiogen P/E ratioAgilent Technologies dividend yieldBiogen dividend yieldAgilent Technologies ROEBiogen ROEAgilent Technologies operating marginBiogen operating marginAgilent Technologies revenue growthBiogen revenue growthAgilent Technologies free cash flowBiogen free cash flow
Agilent Technologies & Biogen appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 29, 2026.